Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Mar 15;292(6522):721–723. doi: 10.1136/bmj.292.6522.721

Amodiaquine induced agranulocytosis and liver damage.

K A Neftel, W Woodtly, M Schmid, P G Frick, J Fehr
PMCID: PMC1339778  PMID: 3082410

Abstract

Seven cases of agranulocytosis and two of liver damage that were probably due to amodiaquine treatment were studied. In five cases agranulocytosis was combined with liver damage, and in one case of primary liver damage moderate neutropenia was present. Three patients died. High total doses or prolonged duration of treatment, or both, appear to favour the occurrence of these reactions. The clustering of five of the seven cases of agranulocytosis within six months in one medical centre indicates that the risk to benefit ratio of amodiaquine for malaria prophylaxis should be re-evaluated.

Full text

PDF
721

Images in this article

722FIG 1
on p.722
723FIG 2
on p.723

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEPLER C. R., BAIER H. N., McCRACKEN S., RENTSCHLER C. L., ROGERS F. B., LANSBURY J. A 15 month controlled study of the effects of amodiaquine (camoquin) in rheumatoid arthritis. Arthritis Rheum. 1959 Oct;2:403–413. doi: 10.1002/1529-0131(195910)2:5<403::aid-art1780020505>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  2. GLICK L. Fatal agranulocytosis during treatment with a amodiaquine. Br Med J. 1957 Apr 20;1(5024):932–932. doi: 10.1136/bmj.1.5024.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gonasun L. M., Potts A. M. In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine. Invest Ophthalmol. 1974 Feb;13(2):107–115. [PubMed] [Google Scholar]
  4. KENNEDY A. F. Absolute neutrophil leucopenia after uncontrolled use of amodiaquine. Br Med J. 1955 Aug 20;2(4937):475–476. doi: 10.1136/bmj.2.4937.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LOVE J., FOULK R., WILLIAMS R. G. W., Jr, MITCHELL R. B. Evaluation of amodiaquin (camoquin) in the treatment of relapsing vivax malaria. Am J Med Sci. 1953 Jan;225(1):26–33. [PubMed] [Google Scholar]
  6. Lepeu G., Codine P., Janbon F., Bertrand A. Agranulocytose à l'amodiaquine. Nouv Presse Med. 1981 Sep 26;10(34):2827–2828. [PubMed] [Google Scholar]
  7. PERRY H. O., BARTHOLOMEW L. G., HANLON D. G. Nearly fatal reaction to amodiaquine. JAMA. 1962 Feb 24;179:598–601. doi: 10.1001/jama.1962.03050080010003. [DOI] [PubMed] [Google Scholar]
  8. POMEROY H., WARREN C., MILLS D., CLARK G. M. The effect of amodiaquin (camoquin) on the course of rheumatoid arthritis. Arthritis Rheum. 1959 Oct;2:396–402. doi: 10.1002/1529-0131(195910)2:5<396::aid-art1780020504>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  9. SCHMID M., HEFTI M. L., GATTIKER R., KISTLER H. J., SENNING A. BENIGN POSTOPERATIVE INTRAHEPATIC CHOLESTASIS. N Engl J Med. 1965 Mar 18;272:545–550. doi: 10.1056/NEJM196503182721101. [DOI] [PubMed] [Google Scholar]
  10. Schulthess H. K., von Felten A., Gmür J., Neftel K. Amodiaquin-induzierte Agranulozytose bei Malariaprophylaxe: Nachweis eines amodiaquin-abhängigen zytotoxischen Antikörpers gegen Granulozyten. Schweiz Med Wochenschr. 1983 Dec 17;113(50):1912–1913. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES